Abstract
We disclose herein the synthesis and characterization of L2Cu(III)2O2 and L3Cu(III)Cu(II)2O2 complexes with nitrogen ligation exclusively from imidazoles for the first time. Their accessibility by direct oxygenation of a L-Cu(I) precursor and the resulting Cu(III) formation inform on the kinetic accessibility and thermodynamic superiority of imidazole in stabilizing Cu(III).
Graphical Abstract
Direct oxygenation of imidazole-ligated Cu(I) generates dinuclear and trinuclear Cu(III) species with exclusive imidazole ligation.

In biological systems, copper is one of the two most used metals for activating dioxygen. The resulting copper-dioxygen (Cux-O2) assemblies adopt myriad structures with varied nuclearity and degree of O2 reduction, with the Cu oxidized to the Cu(I) or Cu(II) oxidation states.1,2 Despite the diversity of oxidant structures and substrates, these Cux-O2 active sites retain remarkably similar ligation spheres, with dominant ligation from histidine-derived imidazole groups.3,4 As imidazole ligands present a synthetic challenge,5–8 synthetic mimics often use Cu(I) complexes with abiological nitrogenous ligation – such as amines,9,10 pyridines,11,12 pyrazoles,13–15 guanidines,16,17 and anionic chelates18,19 – that frequently oxygenate to Cu(III)-containing species such as dicopper(III) bis-μ-oxide (O) or trinuclear bis(μ3-oxide)Cu(III)Cu(II)2 (T) species at low temperatures.20 While Cu(III) has been proposed to be operative in biological intermediates,21–25 it has yet to be spectroscopically characterized in any system.3 This apparent disconnect between synthetic and biological systems is attributed frequently to the greater basicity of the common synthetic ligands compared to the predominance of imidazole ligation in biology.26,27 Recently, we reported that histamine with mixed imidazole and primary amine ligation could stabilize a Cu(III) O species at low temperatures,28 and that direct oxygenation of a histamine-Cu(I) complex forms a Cu(III)-containing T species directly.29 Whether this reactivity is allowed only by the highly basic amine ligation or whether imidazole alone is capable of stabilizing Cu(III) is unknown, as all literature precedents of direct oxygenation of Cu(I) species with exclusive nitrogen ligation from imidazole yield Cu(II) complexes.
Herein we report the direct and indirect synthesis of an OL species with exclusive imidazole ligation that uses bis(1-n-butylimidazole)methane, LnBuBIM, a bidentate, bis-imidazole ligand, to create OnBuBIM. The direct oxygenation of LnBuBIM-Cu(I) forms Cu(III) species OnBuBIM and TnBuBIM at low temperatures. Clean formation of OnBuBIM is also possible through ligand exchange reactions from other preformed OL complexes. Optical monitoring of ligand competition experiments among OL species clearly demonstrates that LnBuBIM is the most donating and thermodynamically stabilizing ligand for Cu(III) investigated to date, despite being less basic than the majority of other O-stabilizing ligands.
As most Cux-O2 species formed by oxygenation are strong oxidants with limited lifetimes at 25 °C, synthetic L2Cu(III)2O2 complexes (OL) are assembled generally at low temperatures by direct injection of a L-Cu(I) precursor into an equilibrated O2 solution.10 For example, tetramethylpropylenediamine (LTMPD) forms OTMPD in 90% yield in 1 min at −125 °C from LTMPD-Cu(I) and O2, and near quantitative yields after 5 min. This complex is a convenient synthon for other OL complexes of greater thermodynamic stability by simple ligand exchange; mixed tertiary amine and imidazole ligation can be achieved by addition of 2 equiv of Nα,Nα,Nτ-trimethyl-histamine (LMe3His) to OTMPD, forming OMe3His in high yields by LTMPD displacement. As the only difference between these ligands is the substitution of 2 tertiary amines for 2 imidazoles, this ligand exchange evidences thermodynamic stabilization of Cu(III) by partial imidazole ligation over peralkylated amine ligation.28
Complete monodentate imidazole ligation of an OL species is thermodynamically precluded as addition of 4 equiv. of 1-methylimidazole (L1MeImd) to OTMPD at −145 °C results in a mixture of the dicopper(II) μ-η2:η2-side-on peroxide, SP1MeImd, species30 and OTMPD starting material under all reaction conditions examined (Figure S1). To encourage coordination of only two imidazoles to an O species, LnBuBIM, a bidentate, bis-imidazole chelating ligand (Scheme S1/S2) was used in a similar core-capture experiment; 2 equiv of LnBuBIM added to OTMPD at −125 °C in 2-methyltetrahydrofuran (2-MeTHF) produces OnBuBIM in ca. 5 min (Figures 1 and 2), evidenced by two new intense ligand-to-metal charge transfer (LMCT) transitions at 349 and 251 nm (Figure 2).31,32 OnBuBIM is formed in greater than 80% yield established through independent redox titrations with 5,6-isopropylidene ascorbic acid (Figure 2 inset, Figure S7) and ferrocenecarboxylic acid and exhibits a half-life of ca. 60 min at −125 °C. Cu K-edge X-ray absorption spectra (XAS) show a clean pre-edge transition at 8980.7 eV suggestive of Cu(III) (Figure S9).33 Extended X-ray absorption fine structure (EXAFS) analysis reveals a Cu-Cu distance of 2.78 Å and a Cu-Navg. of 1.94 Å, both distances the shortest known for OL compounds, consistent with sterically undemanding ligation (Table 1, Figure S10). Significantly improved EXAFS fits result from incorporation of Cu-imidazole multiple scattering, supporting direct imidazole ligation to Cu(III) centers. The metrical trends and optical spectra are recapitulated in the DFT optimized structures (Table 1) and their corresponding TD-DFT spectra (Figure S5).34,35
Figure 1.

Templated core capture synthetic methodology to generate OnBuBIM.
Figure 2.

UV-Vis absorption spectra of OnBuBIM (λmax = 349, 251 nm, red trace) generated from OTMPD (black trace) at −125 °C. [Cu] = 0.9 mM, 0.1 cm path, 2-MeTHF. Inset: titration of the 349 nm feature of OnBuBIM by ascorbic acid.
Table 1.
Physical Properties of Relevant OL Complexes.
| Entry | Compound[a] | UV-Vis: λmax, nm; (ε, mM−1 cm−1)[a,b,c,d] |
Metrical parameters: EXAFS, Å[d]; (DFT, Å[e]) | ||
|---|---|---|---|---|---|
| Cu-Cu | Cu-O | Cu-N | |||
| A | OTMPD[b] | 403 (29.4), 302 (18.7) | 2.85 (2.77) | 1.84 (1.77) | 2.02 (1.97) |
| B | OPD[b] | 375 (22.6), 278 (21.0) | 2.77 (2.66) | 1.86 (1.76) | 2.00 (1.91) |
| C | OMe3His[c] | 380 (30.2), 280 (24.5) | 2.80 (2.72) | 1.82 (1.77) | 1.97 (1.95, 1.89) |
| D | OnBuHis[c] | 363 (27.8), 262 (34.2) | 2.78 (2.69) | 1.82 (1.77) | 1.96 (1.91, 1.88) |
| E | OnBuBIM | 349 (24.1), 251 (35.1) | 2.78 (2.69) | 1.84 (1.76) | 1.94 (1.89) |
The systematic blue-shifting in optical transitions between the OL species listed in Table 1 is suggestive of stronger donation and bonding from the nitrogenous ligands, the only varying parameter between all the complexes. The accepting orbital of the LMCT is predominantly a Cu-N antibonding orbital. An increase in donation from the nitrogenous ligand increases the energy of this antibonding orbital resulting in a higher energy transition. For example, OMe3His (Table 1 entry C: λmax = 380 nm, Cu-N (EXAFS) = 1.97 Å) absorbs at higher energies than OTMPD (Table 1 entry A: λmax = 403 nm, Cu-N (EXAFS) = 2.02 Å) as the imidazole bonds closer to the Cu center in comparison to tertiary amines. Similarly, OnBuHis (Table 1 entry D: λmax = 363 nm, Cu-N (EXAFS) = 1.96 Å) exhibits blue-shifting and contraction from the propylene diamine (LPD) ligated O species, OPD (Table 1 entry B: λmax = 375 nm, Cu-N (EXAFS) = 2.00 Å), supporting that imidazoles form stronger interactions, presumably through increased σ-donation, than do primary amines to the Cu center.31 The optical and structural features of OnBuBIM (Table 1 entry E: λmax = 349 nm, Cu-N (EXAFS) = 1.94 Å) are consistent with these findings, as OnBuBIM exhibits the most blue-shifted optical transition (Figure S4) and shortest Cu-N bond distances of any O species. These observations are further corroborated by DFT and TD-DFT calculations (Figure S5).
The relative thermodynamic stability between imidazole-containing O species such as OMe3His, OnBuHis and OnBuBIM is established by ligand competition core capture experiments. Two equiv of LnBuBIM sequesters the Cu2O2 core from OMe3His, with a blue-shift in the optical spectrum (Figure S6), while the reverse ligand exchange reaction between LMe3His and OnBuBIM is not observed. DFT calculations support these thermodynamic rankings through a computed isodesmic ligand exchange reaction, where OnBuBIM is favored over OMe3His by ca. 8 kcal•mol−1 (Figure 3). Likewise, addition of 2 equiv LnBuHis to OnBuBIM leads to no significant optical shift, whereas addition of 2 equiv LnBuBIM to OnBuHis leads to a rapid initial blue-shift of the characteristic LMCT bands, followed by a rapid decay, attributed to concomitant Cu2O2 core capture and oxidation of the free primary amine. Overall, this suggests that OnBuBIM is more thermodynamically stable than OnBuHis, the most stable O species previously identified, and further supports the energetic preference of imidazole ligation to Cu(III). Combined with the observation of OnBuBIM having the most blue-shifted λmax, these results suggest that exclusive imidazole ligation donates more strongly into the Cu(III) centers than any other combination of neutral, nitrogenous ligation studied and produces the most thermodynamically stable OL species to date.
Figure 3.

DFT calculated isodesmic ligand exchange reactions. Optimized at the CAM-B3LYP/6–31g*/SMD(THF) level with def2tzvp and DKH2 relativistic corrections for single point energy calculations. Red X over the reverse reaction indicates that reversibility was not observed experimentally even in presence of excess ligand.
Direct oxygenation of LnBuBIM-Cu(I) at −125 °C results in a new optical spectrum inconsistent with OnBuBIM, but reminiscent of a L3Cu(III)Cu(II)2O2 trinuclear, TL, cluster with an intense feature at 310 nm and two lesser intensity visible features at 495 and 630 nm (Figure 4).11,29,36 The EXAFS data show a characteristically short Cu-Cuavg. distance of 2.66 Å as well as both Cu(III) and Cu(II) pre-edges at 8980.4 and 8979.1 eV, respectively, consistent with the compact Cu3O2 bis-oxide species, TnBuBIM (Figures 4A, S3, S11, and S12).37 Altering the oxygenation reaction conditions to afford high [O2]–[Cu(I)] ratios at low overall concentrations, the characteristic 349 nm LMCT of OnBuBIM is observed initially at −145 °C.29 Using its known extinction coefficient from the synthesis by ligand exchange described above, formation by oxygenation is estimated at 15% (Figure S2). TnBuBIM forms subsequently over 2 min, resulting in a mixture of two different Cu(III)-containing species formed directly from the oxygenation of a Cu(I)-imidazole precursor (Figure 4B). Taken together, these experiments suggest that exclusive imidazole ligation of Cu(III) is not only thermodynamically favorable, but also kinetically accessible from imidazole-ligated Cu(I) and O2.31,38
Figure 4.

A) Oxygenation of LnBuBIM-Cu(I) ([Cu] = 0.9 mM, 0.1 cm, 2-MeTHF, −125 °C). Inset: Titration of the 310 nm feature of TnBuBIM by incremental addition of cobaltocene (Figure S8). B) Oxygenation of LnBuBIM-Cu(I) ([Cu] = 0.1 mM, 1 cm, 4:1 2-MeTHF:T THF, −145 °C). Beginning OnBuBIM formation is shown in red with subsequent TnBuBIM formation in grey/black.
The characterization of OnBuBIM demonstrates that the Cu(III) oxidation state in a CuX-O2 core is viable in an exclusive imidazole ligation environment as found in biological systems. What is most surprising is that – despite the greater basicity of synthetic ligand substitutes – the observation of short Cu-Nimidazole bond distances, the most blue-shifted λmax for an O species to date, and the isodesmic ligand exchange calculations all suggest that, among bidentate ligands, imidazoles are in fact the most stabilizing neutral, nitrogenous ligation moiety for these high-valent Cu(III) O species. The blue-shift in λmax for OnBuBIM relative to previously reported O species is especially noteworthy as the energy ranges for O and SP LMCT features now overlap such that characterization of Cu(III) vs Cu(II) oxidation states should not be determined by optical transition energies alone. A detailed study of the stereoelectronic compositions of these complexes and how ligation affects their thermodynamic stabilities and optical properties is underway currently.
Supplementary Material
Acknowledgments
This work was supported by the National Institutes of Health (GM120187).
Footnotes
Electronic Supplementary Information (ESI) available: [details of any supplementary information available should be included here]. See DOI: 10.1039/x0xx00000x
Conflicts of interest
There are no conflicts to declare.
Notes and references
- 1.Mirica LM, Ottenwaelder X and Stack TDP, Chem. Rev., 2004, 104, 1013–1045. [DOI] [PubMed] [Google Scholar]
- 2.Elwell CE, Gagnon NL, Neisen BD, Dhar D, Spaeth AD, Yee GM and Tolman WB, Chem. Rev., 2017, 117, 2059–2107. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 3.Solomon EI, Heppner DE, Johnston EM, Ginsbach JW, Cirera J, Qayyum M, Kieber-Emmons MT, Kjaergaard CH, Hadt RG and Tian L, Chem. Rev., 2014, 114, 3659–3853. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 4.Holm RH, Kennepohl P and Solomon EI, Chem. Rev., 1996, 96, 2239–2314. [DOI] [PubMed] [Google Scholar]
- 5.Himes RA, Park GY, Barry AN, Blackburn NJ and Karlin KD, J. Am. Chem. Soc., 2007, 129, 5352–5353. [DOI] [PubMed] [Google Scholar]
- 6.Garcia-Bosch I, Company A, Frisch JR, Torrent-Sucarrat M, Cardellach M, Gamba I, Guell M, Casella L, Que L, Ribas X, Luis JM and Costas M, Angew. Chem. Int. Ed., 2010, 49, 2406–2409. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 7.Casella L, Carugo O, Gullotti M, Doldi S and Frassoni M, Inorg. Chem., 1996, 35, 1101–1113. [DOI] [PubMed] [Google Scholar]
- 8.Concia AL, Beccia MR, Orio M, Ferre FT, Scarpellini M, Biaso F. d. r., Guigliarelli B, Réglier M and Simaan AJ, Inorg. Chem., 2017, 56, 1023–1026. [DOI] [PubMed] [Google Scholar]
- 9.Cole AP, Mahadevan V, Mirica LM, Ottenwaelder X and Stack TDP, Inorg. Chem., 2005, 44, 7345–7364. [DOI] [PubMed] [Google Scholar]
- 10.Citek C, Lin B-L, Phelps TE, Wasinger EC and Stack TDP, J. Am. Chem. Soc., 2014, 136, 14405–14408. [DOI] [PubMed] [Google Scholar]
- 11.Itoh S, Nagagawa M and Fukuzumi S, J. Am. Chem. Soc., 2001, 123, 4087–4088. [DOI] [PubMed] [Google Scholar]
- 12.Jacobson RR, Tyeklár Z, Farooq A, Karlin KD, Liu S and Zubieta J, J. Am. Chem. Soc., 1988, 110, 3690–3692. [Google Scholar]
- 13.Jones PL, Jeffery JC, Maher JP, McCleverty JA, Rieger PH and Ward MD, Inorg. Chem., 1997, 36, 3088–3095. [DOI] [PubMed] [Google Scholar]
- 14.Wilfer C, Liebhåuser P, Hoffmann A, Erdmann H, Grossmann O, Runtsch L, Paffenholz E, Schepper R, Dick R, Bauer M, Dürr M, Ivanović-Burmazović I and Herres-Pawlis S, Chemistry — A European Journal, 2015, 21, 17639–17649. [DOI] [PubMed] [Google Scholar]
- 15.Fujisawa K, Ono T, Ishikawa Y, Amir N, Miyashita Y, Okamoto K.-i. and Lehnert N, Inorg. Chem., 2006, 45, 1698–1713. [DOI] [PubMed] [Google Scholar]
- 16.Herres-Pawlis S, Flörke U and Henkel G, Eur. J. Inorg. Chem., 2005, 3815–3824. [Google Scholar]
- 17.Strassl F, Grimm-Lebsanft B, Rukser D, Biebl F, Biednov M, Brett C, Timmermann R, Metz F, Hoffmann A, Rübhausen M and Herres-Pawlis S, Eur. J. Inorg. Chem., 2017, 2017, 3350–3359. [Google Scholar]
- 18.Dhar D, Yee GM, Markle TF, Mayer JM and Tolman WB, Chem. Sci., 2017, 8, 1075–1085. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 19.Hill LMR, Gherman BF, Aboelella NW, Cramer CJ and Tolman WB, Dalton Trans., 2006, 4944–4953. [DOI] [PubMed] [Google Scholar]
- 20.Stack TDP, Dalton Trans., 2003, 10, 1881–1889. [Google Scholar]
- 21.Cao L, Caldararu O, Rosenzweig AC and Ryde U, Angew. Chem. Int. Ed., 2018, 57, 162–166. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 22.Shiota Y and Yoshizawa K, Inorg. Chem., 2009, 48, 838–845. [DOI] [PubMed] [Google Scholar]
- 23.Yoshizawa K, Kihara N, Kamachi T and Shiota Y, Inorg. Chem., 2006, 45, 3034–3041. [DOI] [PubMed] [Google Scholar]
- 24.Walton PH and Davies GJ, Curr. Opin. Chem. Biol., 2016, 31, 195–207. [DOI] [PubMed] [Google Scholar]
- 25.Keown W, Gary JB and Stack TDP, J. Biol. Inorg. Chem., 2017, 22, 289–305. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 26.Esguerra KVN and Lumb J-P, Synthesis, 2019, 51, 334–358. [Google Scholar]
- 27.Sundberg RJ and Martin RB, Chem. Rev., 1974, 74, 471–517. [Google Scholar]
- 28.Citek C, Gary JB, Wasinger EC and Stack TDP, J. Am. Chem. Soc., 2015, 137, 6991–6994. [DOI] [PubMed] [Google Scholar]
- 29.Gary JB, Citek C, Brown TA, Zare RN, Wasinger EC and Stack TDP, J. Am. Chem. Soc., 2016, 138, 9986–9995. [DOI] [PubMed] [Google Scholar]
- 30.Chiang L, Keown W, Citek C, Wasinger EC and Stack TDP, Angew. Chem. Int. Ed., 2016, 55, 10453–10457. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 31.Citek C, Herres-Pawlis S and Stack TDP, Acc. Chem. Res., 2015, 48, 2424–2433. [DOI] [PubMed] [Google Scholar]
- 32.Henson MJ, Mukherjee P, Root DE, Stack TDP and Solomon EI, J. Am. Chem. Soc., 1999, 121, 10332–10345. [Google Scholar]
- 33.DuBois JL, Mukherjee P, Stack TDP, Hedman B, Solomon EI and Hodgson KO, J. Am. Chem. Soc., 2000, 122, 5775–5787. [Google Scholar]
- 34.Goswami VE, Walli A, Forster M, Dechert S, Demeshko S, Holthausen MC and Meyer F, Chem. Sci., 2017, 8, 3031–3037. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 35.All attempts to stabilize OnBuBIM with a monodeprotonated, anionic form of LnBuBIM (i.e. deprotonation of OnBuBIM with exogenous base or ligand exchange with deprotonated LnBuBIM result in decomposition of the O species. Addition of acids or H-atom donors to OnBuBIM in attempts to protonate the potentially deprotonated ligand did not return isolated ligand. See reference 34.
- 36.Cole AP, Root DE, Mukherjee P, Solomon EI and Stack TDP, Science, 1996, 273, 1848–1850. [DOI] [PubMed] [Google Scholar]
- 37.Decamethyl ferrocene titrations suggest ca. 80% formation (Figure S8) with the assumption of trinuclear as a one-electorn oxidant.
- 38.Chen P and Solomon EI, J. Am. Chem. Soc., 2004, 126, 4991–5000. [DOI] [PubMed] [Google Scholar]
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.
